Tech Brew Ride Home
OpenAI And Microsoft Make Up And Make Nice?
· Summarized
Key takeaways
- OpenAI and Microsoft are negotiating a revised partnership that allows OpenAI to restructure and operate more independently.
- Apple's FDA-cleared hypertension notification feature on the Apple Watch could help diagnose and manage high blood pressure for many users.
- The appointment of an AI bot to combat public sector corruption in Albania highlights both innovative governance and the risks associated with AI.
- AI tools have yet to make significant strides in drug discovery, yet the travel industry is rapidly adopting AI technologies to enhance customer interactions.
Summary
OpenAI and Microsoft's Revised Partnership
OpenAI and Microsoft have signed a non-binding memorandum of understanding to revise their partnership, allowing OpenAI more operational freedom as it transitions from a nonprofit to a public benefit corporation (PBC). Key elements include a modified clause regarding Microsoft's access to OpenAI's technology if artificial general intelligence (AGI) is achieved. Both companies will renegotiate financial terms while ensuring the nonprofit parent organization maintains a significant equity stake.
Apple Watch Receives FDA Clearance for Hypertension Alerts
Apple has received FDA clearance for its new hypertension notifications feature on the Apple Watch, which is set to launch in over 150 countries. This feature utilizes heart rate data to alert users of potential hypertension, encouraging proactive healthcare conversations. Apple estimates that this will notify approximately one million undiagnosed hypertension patients in its first year.
AI's Role in Combating Corruption in Albania
Albania has appointed an AI bot named Diela as a virtual minister to manage and award public procurement in an effort to combat corruption. This move comes in light of historical challenges with corruption in public tendering processes. While Diela aims to ensure transparency, there are concerns about the potential for manipulation and the effectiveness of AI in governance.
AI in Drug Discovery and Travel Services
Despite earlier optimism regarding AI's role in drug discovery, the healthcare sector has seen limited success in developing new drugs through AI technologies. Major pharmaceutical companies face skepticism about the effectiveness of AI in this area. Additionally, travel companies like Booking.com and Expedia are integrating AI to enhance customer service, potentially disrupting traditional commission models in the $1.6 trillion travel industry.
Sponsors
- Klarna · Klarna helps consumers split the costs into four interest-free payments , With no hidden fees, no confusing terms, and no revolving debt, Klarna has helped save consumers billions in interest.
Show notes
OpenAI and Microsoft say they have ironed out their differences… tentatively. Not officially. I’ll explain why that is interesting. With new FDA clearance for the Apple watch are millions of people about to discover they have hypertension? What if AI is less corrupt than humans? And, of course, the Weekend Longreads Suggestions.
OpenAI and Microsoft reach tentative deal to revise partnership (Axios)
OpenAI Takes Big Steps Toward Its Long-Planned Reorganization (NYTimes)
OpenAI & Microsoft Agree to Agree, Tentatively (Spyglass)
Apple Watch hypertension alerts feature receives FDA clearance (9to5Mac)
Albania appoints AI bot as minister to tackle corruption (Reuters)
Weekend Longreads Suggestions:
Why is AI struggling to discover new drugs? (Financial Times)
Online travel platforms prepare for rise of artificial intelligence ‘agents’ (Financial Times)
Follow this show on AudioBrevity and new episodes get summarized for you. Create a free account